PTGS2 and hepatocellular carcinoma: Specially, the has-miR-16, whose ranking is the first of the prediction result, has been studied by researchers and they found that the cyclooxygenase-2 whose expression has been detected in human hepatocellular carcinoma is a target of has-miR-16 [58].